000056245 001__ 56245 000056245 005__ 20210121114520.0 000056245 0247_ $$2doi$$a10.1155/2015/729392 000056245 0248_ $$2sideral$$a91169 000056245 037__ $$aART-2015-91169 000056245 041__ $$aeng 000056245 100__ $$aAra, M. 000056245 245__ $$aRepeatability and Reproducibility of Retinal Nerve Fiber Layer Parameters Measured by Scanning Laser Polarimetry with Enhanced Corneal Compensation in Normal and Glaucomatous Eyes 000056245 260__ $$c2015 000056245 5060_ $$aAccess copy available to the general public$$fUnrestricted 000056245 5203_ $$aObjective. To assess the intrasession repeatability and intersession reproducibility of peripapillary retinal nerve fiber layer (RNFL) thickness parameters measured by scanning laser polarimetry (SLP) with enhanced corneal compensation (ECC) in healthy and glaucomatous eyes. Methods. One randomly selected eye of 82 healthy individuals and 60 glaucoma subjects was evaluated. Three scans were acquired during the first visit to evaluate intravisit repeatability. A different operator obtained two additional scans within 2 months after the first session to determine intervisit reproducibility. The intraclass correlation coefficient (ICC), coefficient of variation (COV), and test-retest variability (TRT) were calculated for all SLP parameters in both groups. Results. ICCs ranged from 0.920 to 0.982 for intravisit measurements and from 0.910 to 0.978 for intervisit measurements. The temporal-superior-nasal- inferior-temporal (TSNIT) average was the highest (0.967 and 0.946) in normal eyes, while nerve fiber indicator (NFI; 0.982) and inferior average (0.978) yielded the best ICC in glaucomatous eyes for intravisit and intervisit measurements, respectively. All COVs were under 10% in both groups, except NFI. TSNIT average had the lowest COV (2.43%) in either type of measurement. Intervisit TRT ranged from 6.48 to 12.84. Conclusions. The reproducibility of peripapillary RNFL measurements obtained with SLP-ECC was excellent, indicating that SLP-ECC is sufficiently accurate for monitoring glaucoma progression. 000056245 536__ $$9info:eu-repo/grantAgreement/ES/ISCIII/FIS/PI11-01392 000056245 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/ 000056245 590__ $$a2.134$$b2015 000056245 591__ $$aMEDICINE, RESEARCH & EXPERIMENTAL$$b72 / 124 = 0.581$$c2015$$dQ3$$eT2 000056245 591__ $$aBIOTECHNOLOGY & APPLIED MICROBIOLOGY$$b81 / 161 = 0.503$$c2015$$dQ3$$eT2 000056245 592__ $$a0.854$$b2015 000056245 593__ $$aBiochemistry, Genetics and Molecular Biology (miscellaneous)$$c2015$$dQ2 000056245 593__ $$aMedicine (miscellaneous)$$c2015$$dQ2 000056245 593__ $$aImmunology and Microbiology (miscellaneous)$$c2015$$dQ2 000056245 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion 000056245 700__ $$0(orcid)0000-0002-2914-2593$$aFerreras, A.$$uUniversidad de Zaragoza 000056245 700__ $$aPajarin, A.B. 000056245 700__ $$0(orcid)0000-0002-6202-2382$$aCalvo, P.$$uUniversidad de Zaragoza 000056245 700__ $$aFigus, M. 000056245 700__ $$aFrezzotti, P. 000056245 7102_ $$11004$$2646$$aUniversidad de Zaragoza$$bDpto. Cirugía,Ginecol.Obstetr.$$cÁrea Oftalmología 000056245 773__ $$g2015 (2015), 729392 [6 pp]$$pBioMed res. int.$$tBioMed Research International$$x2314-6133 000056245 8564_ $$s174433$$uhttps://zaguan.unizar.es/record/56245/files/texto_completo.pdf$$yVersión publicada 000056245 8564_ $$s94143$$uhttps://zaguan.unizar.es/record/56245/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000056245 909CO $$ooai:zaguan.unizar.es:56245$$particulos$$pdriver 000056245 951__ $$a2021-01-21-11:02:19 000056245 980__ $$aARTICLE